rs1047972
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common/normal |
Make rs1047972(A;A) |
Make rs1047972(A;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 20 |
Position | 56386407 |
Gene | AURKA |
is a | snp |
is | mentioned by |
dbSNP | rs1047972 |
dbSNP (classic) | rs1047972 |
ClinGen | rs1047972 |
ebi | rs1047972 |
HLI | rs1047972 |
Exac | rs1047972 |
Gnomad | rs1047972 |
Varsome | rs1047972 |
LitVar | rs1047972 |
Map | rs1047972 |
PheGenI | rs1047972 |
Biobank | rs1047972 |
1000 genomes | rs1047972 |
hgdp | rs1047972 |
ensembl | rs1047972 |
geneview | rs1047972 |
scholar | rs1047972 |
rs1047972 | |
pharmgkb | rs1047972 |
gwascentral | rs1047972 |
openSNP | rs1047972 |
23andMe | rs1047972 |
SNPshot | rs1047972 |
SNPdbe | rs1047972 |
MSV3d | rs1047972 |
GWAS Ctlg | rs1047972 |
GMAF | 0.1561 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
influences mitosis
associated with cancer
[PMID 21050672] Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy
[PMID 16465622] Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
[PMID 18854777] Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
[PMID 25253995] Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects
[PMID 26925658] Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.
[PMID 27270838] Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer.
[PMID 29333101] Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma.
[PMID 33050100] Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.